OPKO Health

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OPKO Health and other ETFs, options, and stocks.

About OPK

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. 

CEO
Phillip Frost
CEOPhillip Frost
Employees
2,275
Employees2,275
Headquarters
Miami, Florida
HeadquartersMiami, Florida
Founded
1991
Founded1991
Employees
2,275
Employees2,275

OPK Key Statistics

Market cap
1.15B
Market cap1.15B
Price-Earnings ratio
-15.85
Price-Earnings ratio-15.85
Dividend yield
—
Dividend yield—
Average volume
8.16M
Average volume8.16M
High today
$1.77
High today$1.77
Low today
$1.50
Low today$1.50
Open price
$1.72
Open price$1.72
Volume
12.00M
Volume12.00M
52 Week high
$1.77
52 Week high$1.77
52 Week low
$0.9769
52 Week low$0.9769

Stock Snapshot

OPKO Health(OPK) stock is priced at $1.52, giving the company a market capitalization of 1.15B. It carries a P/E multiple of -15.85.

On 2026-10-17, OPKO Health(OPK) stock moved within a range of $1.50 to $1.77. With shares now at $1.52, the stock is trading +1.4% above its intraday low and -14.1% below the session's peak.

Trading activity shows a volume of 12M, compared to an average daily volume of 8.16M.

Over the past 52 weeks, OPKO Health(OPK) stock has traded between a high of $1.77 and a low of $0.98.

Over the past 52 weeks, OPKO Health(OPK) stock has traded between a high of $1.77 and a low of $0.98.

OPK News

Zacks 14h
OPKO Health to Sell Select BioReference Assets to Labcorp for $722M

OPKO Health (OPK Quick QuoteOPK - Free Report) recently announced an agreement to sell select assets of its wholly owned subsidiary, BioReference Health,...

OPKO Health to Sell Select BioReference Assets to Labcorp for $722M
TipRanks 1d
Labcorp Slides As Costly OPKO Deal Jolts Investors - TipRanks

...

Labcorp Slides As Costly OPKO Deal Jolts Investors - TipRanks
TipRanks 1d
Opko Health Divests Key Lab Assets to Labcorp

Opko Health ( (OPK) ) just unveiled an announcement. On October 14, 2026, OPKO Health and BioReference Health agreed to sell key assets of BioReference’s clini...

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

More OPK News

Benzinga 1d
Crude Oil Moves Higher; Charles Schwab Shares Fall After Q3 Results

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining over 450 points on Thursday. The Dow traded up 0.93% to 52,102.07 while the NA...

Crude Oil Moves Higher; Charles Schwab Shares Fall After Q3 Results
Benzinga 2d
Penske Automotive, OPKO Health, Ericsson And Other Big Stocks Moving Higher On Thursday

U.S. stocks were mixed, with the Dow Jones index gaining around 200 points on Thursday. Shares of Penske Automotive Group, Inc. (NYSE:PAG) rose sharply after t...

Penske Automotive, OPKO Health, Ericsson And Other Big Stocks Moving Higher On Thursday
Seeking Alpha 2d
Labcorp to buy select assets of OPKO’s BioReference Health for up to $872M

Labcorp (LH) has inked a deal worth up to $872M to acquire a portfolio of assets held by BioReference Health LLC, a subsidiary of OPKO Health (OPK), the compani...

Labcorp to buy select assets of OPKO’s BioReference Health for up to $872M

People also own

Based on the portfolios of people who own OPK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.